Volume 66, Issue 12, Pages (December 2011)

Slides:



Advertisements
Similar presentations
The only end-points of therapy that matter are mucosal healing, normal blood work, and negative radiologic studies. Robert N. Baldassano, MD Colman Family.
Advertisements

NEW IMAGING TECHNIQUES IN THE EVALUATION OF CROHNS DISEASE
Genetic testing for high-risk colon cancer patients1 William M. Grady Gastroenterology Volume 124, Issue 6, Pages (May 2003) DOI: /S (03)
The evolving role of MDCT in the assessment of patients with chronic obstructive pulmonary disease S. Karia, R. Mahadeva, A. Balan, J. Babar Clinical Radiology.
How surgeons can find information online? Martin Hewitt International Journal of Surgery Volume 5, Issue 6, Pages (December 2007) DOI: /j.ijsu
The utility of cardiac CT beyond the assessment of suspected coronary artery disease N. Kakouros, J. Giles, N.B. Crundwell, E.T.M. McWilliams Clinical.
A pooled analysis of MRI in the detection of bone marrow infiltration in patients with malignant lymphoma  X.-X. Jiang, Z.-X. Yan, Y.-Y. Song, W.-L. Zhao 
Colloquium on Therapy of Right Heart Failure
A Royal College of Radiologists National Audit of Radiotherapy in the Treatment of Metastatic Spinal Cord Compression and Implications for the Development.
Imaging findings prevent unnecessary surgery in vasitis: An under-reported condition mimicking inguinal hernia  K. Eddy, D. Connell, B. Goodacre, R. Eddy 
Recommendations for the Use of Radiotherapy in Nodal Lymphoma
Ultrasound stratification of the FDG-avid thyroid nodule
Volume 72, Issue 1, Pages (January 2017)
Does the endoscopic appearance of the ileocecal valve suggest the severity of Crohn's disease in the terminal ileum?  Tamás Molnár, Klaudia Farkas, Ferenc.
Hyperbaric Oxygenation in Cardiac and Pulmonary Disease
Air Pollution and Chest Disease
Mitigating the Safety Risks of Drugs With a Focus on Opioids: Are Risk Evaluation and Mitigation Strategies the Answer?  Marta J. Brooks, PharmD  Mayo.
J. Eric Ahlskog, PhD, MD  Mayo Clinic Proceedings 
Approach to diagnosis of infective endocarditis
Pichamol Jirapinyo, Christopher C. Thompson 
Peripheral Arterial Disease: Diagnosis and Management
Biliary Stricture and Negative Cytology: What Next?
Gauree Gupta, Ebbing Lautenbach, James D. Lewis 
Statins in the Treatment of Dyslipidemia in the Presence of Elevated Liver Aminotransferase Levels: A Therapeutic Dilemma  Rossana M. Calderon, MD, Luigi.
Personalized Disease Models on a Chip
Dose-Length Product to Effective Dose Conversion Factors for Common Computed Tomography Examinations Based on Canadian Clinical Experience  Idris A. Elbakri,
Patient-Reported Outcome Measures for Use in Clinical Trials and Clinical Practice in Inflammatory Bowel Diseases: A Systematic Review  Marin J. de Jong,
A 31-Year-Old Patient With Colitis and Perianal Disease
Joel G. Fletcher, James Huprich, Edward V. Loftus, David H
Association of Trough Serum Infliximab to Clinical Outcome After Scheduled Maintenance Treatment for Crohn’s Disease  Elana A. Maser, Renata Villela,
Challenges to the Therapeutic Pipeline for Irritable Bowel Syndrome: End Points and Regulatory Hurdles  Michael Camilleri, Lin Chang  Gastroenterology 
Emergency Department Planning and Resource Guidelines
Bowel sonography in occlusive Crohn's disease
Health-related quality of life in inflammatory bowel disease: Psychosocial, clinical, socioeconomic, and demographic predictors  Anilga Moradkhani, Linda.
Volume 139, Issue 6, Pages (December 2010)
Clinical Genomics in Inflammatory Bowel Disease
AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review  Jean-Frederic Colombel,
Severe Constipation Clinical Gastroenterology and Hepatology
A Test-based Strategy Is More Cost Effective Than Empiric Dose Escalation for Patients With Crohn's Disease Who Lose Responsiveness to Infliximab  Fernando.
Role of early diagnosis and aggressive surgery in the management of invasive pulmonary aspergillosis in neutropenic patients  D. Caillot, L. Mannone,
Personalized Disease Models on a Chip
David H. Bruining, William J. Sandborn 
Hippocampus abdominalis
Best Practices for Patients With Chronic Migraine
Antibacterial drug discovery in the 21st century
Accelerating Patients’ Access to Advanced Therapies in the EU
Adalimumab in Psoriasis: How Much Is Enough?
Prevention of Postoperative Recurrence in Crohn's Disease
Issue Highlights Clinical Gastroenterology and Hepatology
Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome  Lilian Dindo, PhD  Clinical Gastroenterology.
Volume 17, Issue 2, Pages (February 1950)
Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk  E.Jan Irvine, John K. Marshall  Gastroenterology 
Volume 151, Issue 4, Pages (October 2016)
Kenneth N. Huynh, BS, Ba D. Nguyen, MD  Mayo Clinic Proceedings 
Magnetic Resonance Imaging Compared With Ileocolonoscopy in Evaluating Disease Severity in Crohn’s Disease  Jasper Florie, Karin Horsthuis, Daniel W.
Medical Treatment of Overactive Bladder: In Response
Volume 139, Issue 6, Pages e1 (December 2010)
Endoscopic Assessment and Treating to Target Increase the Likelihood of Mucosal Healing in Patients With Crohn’s Disease  Guillaume Bouguen, Barrett G.
Preoperative Smoking Cessation: The Role of the Primary Care Provider
Joshua P. Metlay, Daniel E. Singer  Clinical Microbiology and Infection 
Epidemiology and Natural History of Inflammatory Bowel Diseases
Impact of antibiotic restrictions: the patient's perspective
Volume 70, Issue 10, Pages (November 2006)
Matthew J. Lee, Claire E. Parker, Sarah R
Medical Therapy for Refractory Pediatric Crohn’s Disease
Deeper and deeper into the pediatric small bowel
Suzanne C. Byrne, MD, Brendan Barrett, MD, Rick Bhatia, MD 
Issue Highlights Clinical Gastroenterology and Hepatology
Quiz page December 2003 American Journal of Kidney Diseases
Diagnostic Accuracy of Capsule Endoscopy for Small Bowel Crohn's Disease Is Superior to That of MR Enterography or CT Enterography  Michael Dam Jensen,
Presentation transcript:

Volume 66, Issue 12, Pages 1148-1158 (December 2011) Diagnostic and therapeutic impact of MR enterography in Crohn’s disease  R. Hafeez, S. Punwani, P. Boulos, S. Bloom, S. McCartney, S. Halligan, S.A. Taylor  Clinical Radiology  Volume 66, Issue 12, Pages 1148-1158 (December 2011) DOI: 10.1016/j.crad.2010.12.018 Copyright © 2011 The Royal College of Radiologists Terms and Conditions

Figure 1 Pre and post-MRE diagnostic confidence for the absence or presence of small bowel disease in patients clinically suspected to have small bowel disease, MRE reported as normal (group 1, n=15). In all patients, clinician confidence that there was small bowel disease present changed to confidence that the small bowel disease was absent following normal MRE. Clinical Radiology 2011 66, 1148-1158DOI: (10.1016/j.crad.2010.12.018) Copyright © 2011 The Royal College of Radiologists Terms and Conditions

Figure 2 Pre and post-MRE diagnostic confidence change for the presence of small bowel disease in patients clinically suspected to have small bowel disease with MRE reported as showing abnormal small bowel (group 2). There was a change in 15 (50%) of the group. Overall mean diagnostic confidence increased from 87% increased to 98% after MRE. Clinical Radiology 2011 66, 1148-1158DOI: (10.1016/j.crad.2010.12.018) Copyright © 2011 The Royal College of Radiologists Terms and Conditions

Figure 3 Median diagnostic confidence for all categories pre and post-MRE in patients clinically suspected to have small bowel disease, MRE reported as normal (group 1). DE, disease extent; LTI, limited terminal ileal disease; JE, jejunal disease; ST, stricturing disease; AD, active disease; CoD, colonic disease; EL, extraluminal disease. Clinical Radiology 2011 66, 1148-1158DOI: (10.1016/j.crad.2010.12.018) Copyright © 2011 The Royal College of Radiologists Terms and Conditions

Figure 4 Median diagnostic confidence for all categories pre and post-MRE in patients clinically suspected to have small bowel disease with MRE reported as showing abnormal small bowel (group 2). DE, disease extent; LTI, limited terminal ileal disease; JE, jejunal disease; ST, stricturing disease; AD, active disease; CoD, colonic disease; EL, extraluminal disease. Clinical Radiology 2011 66, 1148-1158DOI: (10.1016/j.crad.2010.12.018) Copyright © 2011 The Royal College of Radiologists Terms and Conditions

Figure 5 Median diagnostic confidence for extent of disease >30cm in patients clinically suspected to have small bowel disease with MRE reported as showing abnormal small bowel (goup 2). Clinical Radiology 2011 66, 1148-1158DOI: (10.1016/j.crad.2010.12.018) Copyright © 2011 The Royal College of Radiologists Terms and Conditions

Figure 6 Percentage of patients with a change in therapeutic strategy after MRE according to diagnostic group. Clinical Radiology 2011 66, 1148-1158DOI: (10.1016/j.crad.2010.12.018) Copyright © 2011 The Royal College of Radiologists Terms and Conditions

Figure 7 Therapeutic strategy before and after MRE in (a) patients clinically suspected to have small bowel disease, MRE reported as normal (group 1, n=15); (b) patients clinically suspected to have small bowel disease with MRE reported as showing abnormal small bowel (group 2, n=30). Key: 1=patient is on no small bowel medication and none will be added; 2=patient is on no small bowel medication but will be started on some; 3=maintain current small bowel medication; 4=reduce dose of current small bowel medication; 5=Increase dose of current small bowel medication; 6=stop current small bowel medication; 7=change current small bowel medication to similar drug class (e.g., conventional or biological); 8=change current small bowel medication to different drug class (e.g., from conventional to biological); 9=refer for surgical therapy; 10=other (please state). Clinical Radiology 2011 66, 1148-1158DOI: (10.1016/j.crad.2010.12.018) Copyright © 2011 The Royal College of Radiologists Terms and Conditions

Clinical Radiology 2011 66, 1148-1158DOI: (10.1016/j.crad.2010.12.018) Copyright © 2011 The Royal College of Radiologists Terms and Conditions

Clinical Radiology 2011 66, 1148-1158DOI: (10.1016/j.crad.2010.12.018) Copyright © 2011 The Royal College of Radiologists Terms and Conditions